[go: up one dir, main page]

CN103626993B - Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof - Google Patents

Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof Download PDF

Info

Publication number
CN103626993B
CN103626993B CN201310541744.XA CN201310541744A CN103626993B CN 103626993 B CN103626993 B CN 103626993B CN 201310541744 A CN201310541744 A CN 201310541744A CN 103626993 B CN103626993 B CN 103626993B
Authority
CN
China
Prior art keywords
glycol monomethyl
monomethyl ether
poly glycol
soybean
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310541744.XA
Other languages
Chinese (zh)
Other versions
CN103626993A (en
Inventor
卫延安
陈龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201310541744.XA priority Critical patent/CN103626993B/en
Publication of CN103626993A publication Critical patent/CN103626993A/en
Application granted granted Critical
Publication of CN103626993B publication Critical patent/CN103626993B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of use phospholipid of natural soybean to prepare pharmaceutical carrier-Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative (MPEG-SPE) and preparation.Comprise the preparation of powdered soybean phospholipid, the preparation of poly glycol monomethyl ether carboxy derivatives and the preparation of MPEG-SPE, characterize the MPEG-SPE performance of preparation, it is about 100nm that result shows that it forms micella in water, and the micelle-forming concentration in its aqueous solution is 10 -6about mol/L, the emulsifying power in water-normal hexane system is better than powdered soybean phospholipid, is suitable for preparing target medicine carrier.Present invention incorporates the advantage of phospholipid of natural soybean, more unsaturated fatty acids is there is in the kephalin utilizing it to contain on the one hand, there is vessel softening, the function reducing cholesterol and reduce blood pressure, make it more be conducive to HUMAN HEALTH, utilize its raw material to be easy to get on the other hand, low price, reduce its production cost, there is larger economic benefit and social benefit.

Description

聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物及其制备Polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative and its preparation

技术领域technical field

本发明涉及一种聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物药物辅料及其制备方法,属于医药化学领域。The invention relates to a polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative drug excipient and a preparation method thereof, belonging to the field of medicinal chemistry.

背景技术Background technique

聚乙二醇单甲醚(二硬脂酰基磷脂酰乙醇胺(脑磷脂)衍生物(MPEG-DSPE)是两亲性聚合物,他在水中可形成聚合物胶束,这种胶束是一种核-壳结构,尺寸在100-200nm。其通常是用于包覆疏水性药物,以增加疏水性药物在人体血液中的溶解度从而发挥药效。由于形成的这种小尺寸聚合物胶束外部是聚乙二醇分子链段,其可以在胶束外表面形成交错覆盖的致密构象云,形成较厚的立体位阻层,阻碍了人体血液内高密度脂蛋白的攻击和细胞的吞噬从而延长了药物在体内的存留时间,使其不至于在达到病变部位之前被消耗。同时这种纳米胶束利用肿瘤、炎症或高血压血管等损伤部位的毛细血管的通透性高于正常血管,同时淋巴排泄能力减弱,具有生物兼容的大分子、药物载体和分子聚集体在体内循环过程中更容易通过病理部位的血管进入组织内并聚集的效应(EPR效应)而具有被动靶向作用,从而使其在抗癌靶向药物中得到广泛的应用。Polyethylene glycol monomethyl ether (distearyl phosphatidylethanolamine (cephalin) derivative (MPEG-DSPE) is an amphiphilic polymer, which can form polymer micelles in water, which is a kind of Core-shell structure with a size of 100-200nm. It is usually used to coat hydrophobic drugs to increase the solubility of hydrophobic drugs in human blood to exert drug effects. Due to the formation of this small-sized polymer micelle It is a molecular chain segment of polyethylene glycol, which can form a dense conformational cloud covered by staggered on the outer surface of the micelles, forming a thicker steric hindrance layer, which hinders the attack of high-density lipoproteins in human blood and the phagocytosis of cells, thereby extending Increase the retention time of the drug in the body, so that it will not be consumed before reaching the lesion. At the same time, this kind of nano-micelle utilizes the permeability of the capillary in the damaged part of the tumor, inflammation or hypertensive blood vessel to be higher than that of the normal blood vessel, and at the same time The ability of lymphatic excretion is weakened, and biocompatible macromolecules, drug carriers and molecular aggregates are more likely to enter the tissue through the blood vessels of the pathological site and accumulate during the circulation in the body (EPR effect), so that they have a passive targeting effect. It has been widely used in anticancer targeted drugs.

目前抗癌靶向药物价格普遍较高,这与药物本身的原料来源和制备方法有重要关系,因此选择低成本的原料和简便的制备方法较为重要。目前报道的制备MPEG-DSPE的方法大致分为两大类,一类是直接使用聚乙二醇或聚乙二醇单甲醚与二硬脂酰基磷脂酰乙醇胺(脑磷脂)在羰基二咪唑的作用下缩合制备(转化率26%)(NoriyukiMaeda,YoshitoTakeuchi,MikiTakada,etal.Synthesisofangiogenesis-targetedpeptideandhydrophobizedpolyethyleneglycolconjugate.Bioorganic&MedicinalChemistryLetters,2004,14:1015-1017),另一类为将聚乙二醇或聚乙二醇单甲醚的羟基转化为羧基再转为有较高活性的中间体活性酯,然后与二硬脂酰基磷脂酰乙醇胺的氨基反应形成酰胺键(Shih-KwangWu,Ting-GungChang,Chin-Lu,etal.SolidPhaseMethodForSynthesisPeptide-Spacer-LipidConjugates,ConjugatesSynthesizedTherebyAndTargetedLiposomesContainingTheSame[P].US:0229017A1,2003-12-11)。这些制备方法都是使用高纯度的二硬脂酰基磷脂酰乙醇胺(脑磷脂)为原料,二硬脂酰基磷脂酰乙醇胺(脑磷脂)的分子量较大且结构比较复杂,其通常采用柱层析和全合成方法制备,反应步鄹较多,反应困难,产率较低,因此较纯净的二硬脂酰基磷脂酰乙醇胺(脑磷脂)的价格非常昂贵(阿拉丁的最新报价为3000元/25mg)。At present, the price of anti-cancer targeted drugs is generally high, which has an important relationship with the source of raw materials and preparation methods of the drug itself. Therefore, it is more important to choose low-cost raw materials and simple preparation methods. The currently reported methods for preparing MPEG-DSPE are roughly divided into two categories, one is the direct use of polyethylene glycol or polyethylene glycol monomethyl ether and distearyl phosphatidylethanolamine (cephalin) in carbonyl diimidazole Condensation preparation under action (conversion rate 26%) (NoriyukiMaeda, YoshitoTakeuchi, MikiTakada, etal.Synthesisofangiogenesis-targetedpeptideandhydrophobizedpolyethyleneglycolconjugate.Bioorganic&MedicinalChemistryLetters,2004,14:1015-1017), another kind is polyethylene glycol or polyethylene glycol The hydroxyl group of ether is converted into carboxyl and then converted into the intermediate active ester with higher activity, then reacts with the amino group of distearoyl phosphatidylethanolamine to form an amide bond (Shih-KwangWu, Ting-GungChang, Chin-Lu, et al.SolidPhaseMethodForSynthesisPeptide -Spacer-Lipid Conjugates, Conjugates Synthesized Thereby And Targeted Liposomes Containing The Same [P]. US: 0229017A1, 2003-12-11). These preparation methods all use high-purity distearoyl phosphatidylethanolamine (cephalin) as a raw material. Distearoyl phosphatidylethanolamine (cephalin) has a relatively large molecular weight and a relatively complex structure. It usually adopts column chromatography and It is prepared by total synthesis method, with many reaction steps, difficult reaction and low yield, so the price of relatively pure distearoylphosphatidylethanolamine (cephalin) is very expensive (the latest quotation of Aladdin is 3000 yuan/25mg) .

发明内容Contents of the invention

本发明的原理是:大豆磷脂主要由磷脂酰胆碱(卵磷脂)和磷脂酰乙醇胺(脑磷脂)组成,它是加工大豆油的一种副产物,价廉易得,其中的脑磷脂中的脂肪酸主要由油酸,亚油酸,棕榈酸,硬脂酸和亚麻酸组成,存在较多的不饱和脂肪酸,具有软化血管,降低胆固醇和降低血压的功能。用其作为原料制备的聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物(MPEG-SPE)不仅成本低于聚乙二醇单甲醚(二硬脂酰基磷脂酰乙醇胺(脑磷脂)衍生物(MPEG-DSPE)而且更有利于人类心血管的健康。The principle of the present invention is: soybean lecithin is mainly composed of phosphatidylcholine (lecithin) and phosphatidylethanolamine (cephalin), which is a by-product of processing soybean oil, which is cheap and easy to get, and the cephalin Fatty acids are mainly composed of oleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid, and there are more unsaturated fatty acids, which have the functions of softening blood vessels, lowering cholesterol and lowering blood pressure. The polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative (MPEG-SPE) prepared with it as a raw material is not only lower in cost than polyethylene glycol monomethyl ether (distearoylphosphatidylethanolamine (cephalin) derivative ( MPEG-DSPE) and more conducive to human cardiovascular health.

因此本发明针对现有的MPEG-DSPE制备所用脑磷脂原料难得,价格昂贵的特点。提供一种使用价格较便宜的天然大豆磷脂制备聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物药物辅料的方法。Therefore, the present invention aims at the rare and expensive characteristics of the cephalin raw materials used in the preparation of the existing MPEG-DSPE. The invention provides a method for preparing pharmaceutical auxiliary materials of polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivatives by using cheaper natural soybean lecithin.

本发明的另一个目的是提供一种聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物。Another object of the present invention is to provide a polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative.

实现本发明目的的技术解决方案是:一种聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物,其结构如下:The technical solution that realizes the object of the present invention is: a kind of polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative, its structure is as follows:

实现本发明另一目的的技术解决方案为:一种聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物的制备,具体步骤如下:The technical solution that realizes another object of the present invention is: a kind of preparation of polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative, concrete steps are as follows:

步骤1:以天然大豆磷脂制备大豆粉末磷脂;Step 1: preparing soybean powder phospholipids with natural soybean phospholipids;

步骤2:以聚乙二醇单甲醚制备聚乙二醇单甲醚羧基衍生物;Step 2: preparing polyethylene glycol monomethyl ether carboxyl derivatives with polyethylene glycol monomethyl ether;

步骤3:以聚乙二醇单甲醚羧基衍生物制备聚乙二醇单甲醚酰氯;Step 3: preparing polyethylene glycol monomethyl ether acid chloride with polyethylene glycol monomethyl ether carboxyl derivatives;

步骤4:以大豆粉末磷脂和聚乙二醇单甲醚酰氯为原料,以三氯甲烷为溶剂,以三乙胺为催化剂,制备聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物,反应条件为m(大豆粉末磷脂):m(聚乙二醇单甲醚酰氯)=1:1~10:1;反应温度为10℃~80℃;反应时间为0.5h~10h;Step 4: Using soybean powder phospholipids and polyethylene glycol monomethyl ether acid chloride as raw materials, using chloroform as a solvent, and triethylamine as a catalyst to prepare polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivatives, reaction conditions It is m (soybean powder phospholipid): m (polyethylene glycol monomethyl ether chloride) = 1: 1 ~ 10: 1; the reaction temperature is 10 ° C ~ 80 ° C; the reaction time is 0.5 h ~ 10 h;

步骤5:反应结束后,除去三氯甲烷和未反应的三乙胺,加入四氢呋喃沉淀出三乙胺的盐酸盐,离心分离,上层液体除去四氢呋喃再加入无水乙醚沉淀出反应产物。Step 5: After the reaction, remove chloroform and unreacted triethylamine, add tetrahydrofuran to precipitate triethylamine hydrochloride, centrifuge, remove tetrahydrofuran from the upper liquid, and then add anhydrous ether to precipitate the reaction product.

步骤1中所述的大豆粉末磷脂采用丙酮萃取法制备。The soybean powder phospholipid described in step 1 is prepared by an acetone extraction method.

步骤2中所述的聚乙二醇单甲醚羧基衍生物采用琼斯试剂氧化聚乙二醇单甲醚法制备,其中聚乙二醇单甲醚的分子量范围为1200~5000。The carboxyl derivative of polyethylene glycol monomethyl ether described in step 2 is prepared by using Jones reagent to oxidize polyethylene glycol monomethyl ether, wherein the molecular weight of polyethylene glycol monomethyl ether ranges from 1200 to 5000.

步骤3中所述的聚乙二醇单甲醚酰氯采用二氯亚砜和聚乙二醇单甲醚羧基衍生物制备。The polyethylene glycol monomethyl ether acid chloride described in step 3 is prepared by using thionyl chloride and polyethylene glycol monomethyl ether carboxyl derivatives.

步骤4中所述的聚乙二醇单甲醚酰氯与三乙胺的物质的量比为:n(聚乙二醇单甲醚酰氯):n(三乙胺)=1:10~1:40。The molar ratio of polyethylene glycol monomethyl ether chloride and triethylamine described in step 4 is: n (polyethylene glycol monomethyl ether chloride):n (triethylamine)=1:10~1: 40.

步骤5中所述的聚乙二醇单甲醚酰氯的物质的量与四氢呋喃体积之比为:n(聚乙二醇单甲醚酰氯(mmol)):v(四氢呋喃(ml))=1:30~1:100,所述的聚乙二醇单甲醚酰氯的物质的量与无水乙醚体积之比为n(聚乙二醇单甲醚酰氯(mmol)):v(无水乙醚(ml))=1:30~1:100。The ratio of the amount of polyethylene glycol monomethyl ether acid chloride to the volume of tetrahydrofuran described in step 5 is: n (polyethylene glycol monomethyl ether acid chloride (mmol)): v (tetrahydrofuran (ml))=1: 30 to 1:100, the ratio of the amount of polyethylene glycol monomethyl ether chloride to the volume of anhydrous ether is n (polyethylene glycol monomethyl ether chloride (mmol)): v (anhydrous ether ( ml))=1:30~1:100.

与现有的MPEG-DSPE药物辅料相比较,本发明结合了天然大豆磷脂的优点,一方面利用其含有的脑磷脂中存在较多的不饱和脂肪酸,具有软化血管,降低胆固醇和降低血压的功能,使其更有利于人体健康,另一方面利用其原料易得,价格便宜,降低了其生产成本,具有较大的经济效益和社会效益。通过以上方法制备的MPEG-SPE的技术效果为:通过TEM观察了MPEG-SPE在水中形成胶束的大小,结果表明,其在水溶液中形成的胶束平均粒径为100nm左右。通过荧光探针技术研究了MPEG-SPE的临界聚集浓度用以表征产物的热力学稳定性,结果表明其在水溶液中的临界胶束浓度为10-6mol/L左右,形成胶束的热力学稳定性优于小分子胶束。通过乳化力来表征MPEG-SPE的动力学稳定性,结果表明其的动力学稳定性优于大豆粉末磷脂,适合于制备靶向药物载体。Compared with the existing MPEG-DSPE pharmaceutical excipients, the present invention combines the advantages of natural soybean phospholipids, on the one hand, it utilizes the cephalin contained in it to contain more unsaturated fatty acids, which has the functions of softening blood vessels, lowering cholesterol and lowering blood pressure , making it more beneficial to human health, on the other hand, the raw materials are easy to get and the price is cheap, which reduces the production cost and has great economic and social benefits. The technical effect of the MPEG-SPE prepared by the above method is: the size of the micelles formed by the MPEG-SPE in water was observed by TEM, and the results showed that the average particle size of the micelles formed in the aqueous solution was about 100nm. The critical aggregation concentration of MPEG-SPE was studied by fluorescent probe technology to characterize the thermodynamic stability of the product. The results showed that its critical micelle concentration in aqueous solution was about 10 -6 mol/L, and the thermodynamic stability of the formed micelles Superior to small molecule micelles. The kinetic stability of MPEG-SPE was characterized by emulsification force, and the results showed that its kinetic stability was better than that of soybean powder phospholipids, and it was suitable for the preparation of targeted drug carriers.

附图说明Description of drawings

图1为本发明MPEG-SPE制备工艺流程图。Fig. 1 is the flow chart of the preparation process of MPEG-SPE of the present invention.

图2为本发明实施例1的MPEG2000-SPE浓度对I384/I373比值的影响图。Fig. 2 is a graph showing the influence of MPEG2000-SPE concentration on the I384/I373 ratio in Example 1 of the present invention.

具体实施方式detailed description

实施例1Example 1

图1中,第一步,称取12g大豆磷脂加入到100ml丙酮中,搅拌至固体出现,减压抽滤,滤饼加入到2支20ml离心管中,分别加入10ml丙酮,在4000r/min的转速下离心2min,倒出液体,重复多次上述过程,直至离心管中液体无色时,取出离心管中固体,放入真空干燥箱中室温干燥24h。In Figure 1, in the first step, weigh 12g of soybean lecithin and add it to 100ml of acetone, stir until solids appear, filter under reduced pressure, add the filter cake to two 20ml centrifuge tubes, add 10ml of acetone respectively, Centrifuge at a rotational speed for 2 minutes, pour out the liquid, and repeat the above process several times until the liquid in the centrifuge tube is colorless, take out the solid in the centrifuge tube, and put it in a vacuum drying oven to dry at room temperature for 24 hours.

第二步,称取5gmPEG2000加入盛有100mL丙酮溶液的500mL烧瓶中,在25℃下磁力搅拌直到mPEG全部溶解。然后加入4.25mL琼斯试剂,反应24h。反应结束后,加入异丙醇淬灭,抽滤,滤液加入50mL蒸馏水,旋蒸除去体系中的丙酮(尽量除尽),剩余溶液中加入一定量的碳酸氢钾,直至体系中无气泡产生为止,蒸干体系中的水,用三氯甲烷对残留物进行充分的萃取,抽滤,滤液旋蒸除去三氯甲烷,而后再向残余物中加入10%的盐酸溶液直至体系pH为1,蒸出水和氯化氢气体,残余物中有氯化钠析出,此时再用三氯甲烷萃取,抽滤,滤液旋蒸除去氯仿,得到产物,冷却后得到白色固体产物。产率:4.90g(98%)。酸值:实际值,0.497mmol羧基/g;理论值,0.500mmol羧基/g。IR:1735cm-1(羰基特征峰),3480cm-1(-OH的伸缩振动峰),1100cm-1(C—O—C的伸缩振动峰)。1HNMR(DMSOd6):δH3.24(-O-CH3),4.01(—O—CH2—COOH的次甲基),3.31-3.58(重复单元—CH2—CH2—O—),12.55(—COOH)。In the second step, weigh 5g of mPEG2000 into a 500mL flask filled with 100mL of acetone solution, and stir magnetically at 25°C until mPEG is completely dissolved. Then add 4.25mL Jones reagent and react for 24h. After the reaction is over, add isopropanol to quench, filter with suction, add 50mL distilled water to the filtrate, remove acetone in the system by rotary evaporation (remove as much as possible), and add a certain amount of potassium bicarbonate to the remaining solution until no bubbles are generated in the system , evaporate the water in the system to dryness, fully extract the residue with chloroform, filter with suction, remove the chloroform by rotary evaporation of the filtrate, then add 10% hydrochloric acid solution to the residue until the pH of the system is 1, evaporate Water and hydrogen chloride gas were discharged, and sodium chloride was precipitated in the residue. At this time, it was extracted with chloroform, filtered with suction, and the filtrate was rotary evaporated to remove chloroform to obtain the product. After cooling, a white solid product was obtained. Yield: 4.90 g (98%). Acid value: actual value, 0.497mmol carboxyl group/g; theoretical value, 0.500mmol carboxyl group/g. IR: 1735cm -1 (characteristic peak of carbonyl), 3480cm -1 (stretching vibration peak of -OH), 1100cm -1 (stretching vibration peak of C—O—C). 1 HNMR (DMSOd 6 ): δ H 3.24 (-O-CH 3 ), 4.01 (methine of -O-CH 2 -COOH), 3.31-3.58 (repeating unit -CH 2 -CH 2 -O-), 12.55 (—COOH).

第三步,称取2gCmPEG2000加入到10ml二氯甲烷中,再向反应体系中加入20ml二氯亚砜,回流反应6h。减压蒸馏,加入无水乙醚沉淀,抽滤,得到白色固体。In the third step, weigh 2g of CmPEG2000 and add it into 10ml of dichloromethane, then add 20ml of thionyl chloride into the reaction system, and react under reflux for 6h. Distill under reduced pressure, add anhydrous diethyl ether to precipitate, and filter with suction to obtain a white solid.

第四步,称取6.0g大豆粉末磷脂溶解到30ml三氯甲烷中,移入到150ml的三口烧瓶中,加入25mmol的三乙胺,磁力搅拌,升温到45,℃将2g聚乙二醇单甲醚2000酰氯溶解到20ml三氯甲烷中,使用滴液漏斗逐滴加入到三口烧瓶中。反应4h。The fourth step is to weigh 6.0g of soybean powder lecithin and dissolve it in 30ml of chloroform, transfer it into a 150ml three-neck flask, add 25mmol of triethylamine, stir it magnetically, heat up to 45, and dissolve 2g of polyethylene glycol monomethyl Ether 2000 acid chloride was dissolved in 20ml of chloroform, and added dropwise into a three-necked flask using a dropping funnel. Reaction 4h.

第五步,反应结束后,旋蒸除去三氯甲烷和未反应的三乙胺。而后加入30ml四氢呋喃沉淀出三乙胺的盐酸盐,离心分离,上层液体除去四氢呋喃再加入20ml无水乙醚沉淀出未反应的聚乙二醇单甲醚2000酰氯和反应产物,分别用10ml无水乙醚洗涤三次,干燥称重。IR:1650cm-1(—C(O)NH—的羰基伸缩振动峰),1533cm-1(—C(O)NH—的氨基面内弯曲振动峰),1100cm-1(C—O—C伸缩振动峰).In the fifth step, after the reaction is finished, chloroform and unreacted triethylamine are removed by rotary evaporation. Then add 30ml of tetrahydrofuran to precipitate the hydrochloride of triethylamine, centrifuge, remove tetrahydrofuran from the upper liquid, add 20ml of anhydrous ether to precipitate unreacted polyethylene glycol monomethyl ether 2000 acid chloride and reaction product, respectively use 10ml of anhydrous Washed three times with ether, dried and weighed. IR: 1650cm-1 (carbonyl stretching vibration peak of —C(O) NH—), 1533cm-1 (bending vibration peak of amino group in-plane of —C(O) NH—), 1100cm-1 (C—O—C stretching vibration peak vibration peak).

实施例2Example 2

第一步,同上first step, ditto

第二步,称取6gmPEG1200加入盛有100mL丙酮溶液的500mL烧瓶中,在25℃下磁力搅拌直到mPEG全部溶解。然后加入8.5mL琼斯试剂,反应24h。后处理方法同上。产率:5.61g(93.5%)。酸值:实际值,0.830mmol羧基/g;理论值,0.833mmol羧基/g。IR:1744cm-1(羰基特征峰),3486cm-1(-OH的伸缩振动峰),1088cm-1(C—O—C的伸缩振动峰)。1HNMR(DMSOd6):δH3.23(-O-CH3),4.01(—O—CH2—COOH的次甲基),3.33-3.50(重复单元—CH2—CH2—O—),12.54(—COOH)。In the second step, weigh 6g of mPEG1200 and add it into a 500mL flask containing 100mL of acetone solution, and stir magnetically at 25°C until mPEG is completely dissolved. Then add 8.5mL Jones reagent and react for 24h. The post-processing method is the same as above. Yield: 5.61 g (93.5%). Acid value: actual value, 0.830 mmol carboxyl group/g; theoretical value, 0.833 mmol carboxyl group/g. IR: 1744cm -1 (carbonyl characteristic peak), 3486cm -1 (stretching vibration peak of -OH), 1088cm -1 (stretching vibration peak of C—O—C). 1 HNMR (DMSOd 6 ): δ H 3.23 (-O-CH 3 ), 4.01 (methine of -O-CH 2 -COOH), 3.33-3.50 (repeating unit -CH 2 -CH 2 -O-), 12.54 (—COOH).

第三步,称取2gCmPEG1200加入到10ml二氯甲烷中,再向反应体系中加入30ml二氯亚砜,回流反应6h。减压蒸馏得到产物。In the third step, weigh 2g of CmPEG1200 and add it into 10ml of dichloromethane, then add 30ml of thionyl chloride into the reaction system, and react under reflux for 6h. The product was obtained by distillation under reduced pressure.

第四步,称取12.0g大豆粉末磷脂溶解到30ml三氯甲烷中,移入到150ml的三口烧瓶中,加入10mmol的三乙胺,磁力搅拌,升温到10,℃将1.2g聚乙二醇单甲醚1200酰氯溶解到20ml三氯甲烷中,使用滴液漏斗逐滴加入到三口烧瓶中。反应0.5h。The fourth step is to weigh 12.0g of soybean powder lecithin and dissolve it in 30ml of chloroform, transfer it into a 150ml three-neck flask, add 10mmol of triethylamine, stir it magnetically, heat up to 10°C and dissolve 1.2g of polyethylene glycol Dimethyl ether 1200 acid chloride was dissolved in 20ml of chloroform, and added dropwise into a three-neck flask using a dropping funnel. Reaction 0.5h.

第五步,反应结束后,旋蒸除去三氯甲烷和未反应的三乙胺。而后加入30ml四氢呋喃沉淀出三乙胺的盐酸盐,离心分离,上层液体除去四氢呋喃,冷却至10℃以下,再加入15ml无水乙醚沉淀出未反应的聚乙二醇单甲醚1200酰氯和反应产物,分别用5ml无水乙醚洗涤三次,干燥称重。IR:1653cm-1(—C(O)NH—的羰基伸缩振动峰),1537cm-1(—C(O)NH—的氨基面内弯曲振动峰),1090cm-1(C—O—C伸缩振动峰).In the fifth step, after the reaction is finished, chloroform and unreacted triethylamine are removed by rotary evaporation. Then add 30ml of tetrahydrofuran to precipitate triethylamine hydrochloride, centrifuge, remove tetrahydrofuran from the upper liquid, cool to below 10°C, add 15ml of anhydrous ether to precipitate unreacted polyethylene glycol monomethyl ether 1200 acid chloride and react The products were washed three times with 5 ml of anhydrous ether, dried and weighed. IR: 1653cm-1 (carbonyl stretching vibration peak of -C(O)NH-), 1537cm-1 (in-plane bending vibration peak of amino group of -C(O)NH-), 1090cm-1 (C—O—C stretching vibration peak vibration peak).

实施例3Example 3

第一步,同上first step, ditto

第二步,称取5gmPEG5000加入盛有100mL丙酮溶液的500mL烧瓶中,在25℃下磁力搅拌直到mPEG全部溶解。然后加入1.7mL琼斯试剂,反应24h。后处理方法同上。产率:4.91g(98.2%)。酸值:实际值,0.196mmol羧基/g;理论值,0.200mmol羧基/g。IR:1732cm-1(羰基特征峰),3480cm-1(-OH的伸缩振动峰),1106cm-1(C—O—C的伸缩振动峰)。1HNMR(DMSOd6):δH3.22(-O-CH3),4.01(—O—CH2—COOH的次甲基),3.33-3.51(重复单元—CH2—CH2—O—)n,12.54(—COOH)。In the second step, weigh 5g of mPEG5000 and add it into a 500mL flask filled with 100mL of acetone solution, and stir magnetically at 25°C until mPEG is completely dissolved. Then add 1.7mL Jones reagent and react for 24h. The post-processing method is the same as above. Yield: 4.91 g (98.2%). Acid value: actual value, 0.196 mmol carboxyl group/g; theoretical value, 0.200 mmol carboxyl group/g. IR: 1732cm -1 (carbonyl characteristic peak), 3480cm -1 (stretching vibration peak of -OH), 1106cm -1 (stretching vibration peak of C—O—C). 1 HNMR (DMSOd 6 ): δ H 3.22 (-O-CH 3 ), 4.01 (methine of —O—CH 2 —COOH), 3.33-3.51 (repeating unit—CH 2 —CH 2 —O—)n , 12.54 (—COOH).

第三步,称取5gCmPEG5000加入到10ml二氯甲烷中,再向反应体系中加入30ml二氯亚砜,回流反应6h。减压蒸馏,加入无水乙醚沉淀,抽滤,得到白色固体。In the third step, 5g of CmPEG5000 was weighed and added to 10ml of dichloromethane, and then 30ml of thionyl chloride was added to the reaction system, and the reaction was refluxed for 6h. Distill under reduced pressure, add anhydrous diethyl ether to precipitate, and filter with suction to obtain a white solid.

第四步,称取5g大豆粉末磷脂溶解到30ml三氯甲烷中,移入到150ml的三口烧瓶中,加入40mmol的三乙胺,磁力搅拌,升温到80,℃将5g聚乙二醇单甲醚5000酰氯溶解到20ml三氯甲烷中,使用滴液漏斗逐滴加入到三口烧瓶中。反应10h。Step 4: Dissolve 5g of soybean powder phospholipids into 30ml of chloroform, transfer to a 150ml three-necked flask, add 40mmol of triethylamine, stir magnetically, heat up to 80, ℃ and dissolve 5g of polyethylene glycol monomethyl ether 5000 g of acid chloride was dissolved in 20 ml of chloroform, and added dropwise into a three-necked flask using a dropping funnel. Reaction 10h.

第五步,反应结束后,旋蒸除去三氯甲烷和未反应的三乙胺。而后加入100ml四氢呋喃沉淀出三乙胺的盐酸盐,离心分离,上层液体旋蒸除去四氢呋喃再加入70ml无水乙醚沉淀出未反应的聚乙二醇单甲醚5000酰氯和反应产物,分别用10ml无水乙醚洗涤三次。干燥称重。IR:1655cm-1(—C(O)NH—的羰基伸缩振动峰),1533cm-1(—C(O)NH—的氨基面内弯曲振动峰),1106cm-1(C—O—C伸缩振动峰).In the fifth step, after the reaction is finished, chloroform and unreacted triethylamine are removed by rotary evaporation. Then add 100ml of tetrahydrofuran to precipitate the hydrochloride of triethylamine, centrifuge, remove the tetrahydrofuran by rotary evaporation of the upper layer liquid, then add 70ml of anhydrous ether to precipitate unreacted polyethylene glycol monomethyl ether 5000 acid chloride and the reaction product, respectively use 10ml Washed three times with anhydrous ether. Weigh dry. IR: 1655cm-1 (carbonyl stretching vibration peak of -C(O)NH-), 1533cm-1 (in-plane bending vibration peak of amino group of -C(O)NH-), 1106cm-1 (C—O—C stretching vibration peak vibration peak).

对实施例1制备的聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物进行了性能表征,其结果如下:The performance characterization of the polyethylene glycol monomethyl ether soybean phosphatidylethanolamine derivative prepared in Example 1 is carried out, and the results are as follows:

1.MPEG2000-SPE的胶束粒径:1. The micellar particle size of MPEG2000-SPE:

MPEG2000-SPE是一种聚合物表面活性剂,当其在水中浓度大于临界胶束浓度时可形成以疏水链端为核,亲水链端为核的纳米胶束,可以用来运输药物,当其达到一定的纳米尺寸时具有靶向特性。本部分采用透射电子显微镜测定MPEG2000-SPE的胶束粒径,方法如下:称取一定量的MPEG2000-SPE溶解于水中,常温放置3h,使得MPEG2000-SPE在水中形成稳定的胶束,沾到铜网上,铜网在室温下干燥后,在透射电镜上观察胶束的大小。实验结果表明,MPEG2000-SPE的胶束呈球形,平均粒径在100nm左右,粒子较均匀。MPEG2000-SPE is a polymer surfactant. When its concentration in water is greater than the critical micelle concentration, it can form nano-micelles with hydrophobic chain ends as the core and hydrophilic chain ends as the core. It can be used to transport drugs. It has targeting properties when it reaches a certain nanometer size. In this part, transmission electron microscopy is used to measure the micelle particle size of MPEG2000-SPE. The method is as follows: Weigh a certain amount of MPEG2000-SPE and dissolve it in water, and place it at room temperature for 3 hours, so that MPEG2000-SPE forms stable micelles in water and sticks to copper. On the grid, the size of the micelles was observed on a TEM after the copper grid was dried at room temperature. The experimental results show that the micelles of MPEG2000-SPE are spherical, the average particle diameter is about 100nm, and the particles are relatively uniform.

2.MPEG2000-SPE的热力学稳定性研究:2. Thermodynamic stability research of MPEG2000-SPE:

MPEG2000-SPE在水溶液中可形成胶束,胶束热力学的稳定性指的是聚合物胶束向单体解聚时的浓度,即临界胶束浓度(CMC)也成临界聚集浓度(CAC)。本部分采用灵敏度较高的荧光探针技术来测定MPEG2000-SPE的CAC。方法如下:首先制备1×10-7,2×10-7,3×10-7,5×10-7,7×10-7,1×10-6,2×10-6,3×10-6,5×10-6,1×10-5,2×10-5,3×10-5,5×10-5,7×10-5,10×10-5,15×10-5mol/L浓度的MPEG-SPE溶液,再配置2×10-4mol/L的芘的丙酮溶液,而后取0.1ml芘的丙酮溶液加入10ml容量瓶中,常温下使丙酮挥发掉,用移液枪分别移取10ml上述配置的MPEG2000-SPE溶液加入到容量瓶中,多次震荡后再超声30min。然后在335nm下测定一系列不同浓度的MPEG-SPE溶液在373nm和384nm下的荧光强度,以MPEG2000-SPE浓度的对数为X轴,I384/I373的值为Y轴作图,从图中找出达到CAC时的浓度,如图2所示,当x=-5.69时,I384/I373的值发生突变,说明此时已到达CAC,临界胶束浓度为2×10-6mol/L,远远小于小分子的临界胶束浓度10-3mol/L,因此MPEG-SPE的热力学稳定性优于小分子胶束。MPEG2000-SPE can form micelles in aqueous solution. The thermodynamic stability of micelles refers to the concentration of polymer micelles when they depolymerize to monomers, that is, the critical micelle concentration (CMC) is also the critical aggregation concentration (CAC). In this part, the fluorescent probe technology with high sensitivity is used to measure the CAC of MPEG2000-SPE. The method is as follows: first prepare 1×10 -7 , 2×10 -7 , 3×10 -7 , 5×10 -7 , 7×10 -7 , 1×10 -6 , 2×10 -6 , 3×10 -6 , 5×10 -6 , 1×10 -5 , 2×10 -5 , 3×10 -5 , 5×10 -5 , 7×10 -5 , 10×10 -5 , 15×10 -5 mol/L concentration of MPEG-SPE solution, and then configure 2×10 -4 mol/L pyrene in acetone solution, then take 0.1ml of pyrene in acetone solution and add it to a 10ml volumetric flask. Pipette 10ml of the above-mentioned MPEG2000-SPE solution into the volumetric flask, and then sonicate for 30min after shaking several times. Then measure the fluorescence intensity of a series of MPEG-SPE solutions with different concentrations at 373nm and 384nm at 335nm, take the logarithm of the MPEG2000-SPE concentration as the X-axis, and the value of I384/I373 as the Y-axis plot, find out from the figure As shown in Figure 2, when x=-5.69, the value of I384/I373 changes abruptly, indicating that the CAC has been reached at this time, and the critical micelle concentration is 2×10 -6 mol/L, far from Much smaller than the critical micelle concentration of small molecules (10 -3 mol/L), the thermodynamic stability of MPEG-SPE is better than that of small molecule micelles.

3.MPEG2000-SPE的胶束动力学稳定性研究:3. MPEG2000-SPE study on the kinetic stability of micelles:

聚合物胶束的稳定性通常由热力学稳定性和动力学稳定性评价,其中动力学稳定性是指胶束分解为单体的速度,我们设计由正己烷和水形成的乳状液体系,根据乳状液分离一定体积的液体来表征胶束分解为单体的速度,同等条件下与大豆粉末磷脂进行对比。操作如下:用50ml的蒸馏水溶解0.05g试样,置于100ml的具塞量筒内,量取50ml的正己烷,塞上盖子猛烈振动至充分乳化后,立即计时测定水-油相分开10ml所耗费的时间。实验结果如表1所示:MPEG2000-SPE分开10ml所用时间为183s远远大于大豆粉末磷脂所用时间6s,并且当MPEG-SPE的乳液分出41ml体积后油-水将不再分离,量筒上部呈现稳定的凝胶状态。因此MPEG-SPE的动力学稳定性优于大豆粉末磷脂。The stability of polymer micelles is usually evaluated by thermodynamic stability and kinetic stability. Kinetic stability refers to the speed at which micelles decompose into monomers. We design an emulsion system formed by n-hexane and water. According to the emulsion Liquid separation of a certain volume of liquid to characterize the speed at which micelles decompose into monomers, compared with soybean powder phospholipids under the same conditions. The operation is as follows: dissolve 0.05g sample with 50ml of distilled water, place it in a 100ml stoppered measuring cylinder, measure 50ml of n-hexane, put on the lid and vibrate violently until it is fully emulsified, then measure the water-oil phase separation of 10ml by time immediately time. The experimental results are shown in Table 1: the time taken by MPEG2000-SPE to separate 10ml is 183s, which is far longer than the time taken by soybean powder phospholipids of 6s, and when the MPEG-SPE emulsion is separated into a volume of 41ml, the oil-water will no longer separate, and the upper part of the measuring cylinder will appear stable gel state. Therefore, the kinetic stability of MPEG-SPE is better than soybean powder phospholipids.

表1不同物质的油水两相分开体积与所用时间(s)之间的关系Table 1 The relationship between the volume of oil-water two-phase separation of different substances and the time (s) used

Claims (10)

1. a Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative, is characterized in that structure is as follows:
Wherein R 1, R 2represent the group after any one dehydrogenation in oleic acid, linolenic acid, linolic acid, stearic acid or palmitinic acid, and R 1, R 2it is asynchronously the group after oleic acid, stearic acid or palmitinic acid dehydrogenation.
2. Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 1, is characterized in that described derivative is prepared by following concrete steps:
Step 1, prepares powdered soybean phospholipid with phospholipid of natural soybean;
Step 2, prepares poly glycol monomethyl ether carboxy derivatives with poly glycol monomethyl ether;
Step 3, prepares poly glycol monomethyl ether acyl chlorides with poly glycol monomethyl ether carboxy derivatives;
Step 4, with powdered soybean phospholipid and poly glycol monomethyl ether acyl chlorides for raw material, take trichloromethane as solvent, take triethylamine as catalyzer, preparation Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative, wherein by quality ratio, powdered soybean phospholipid: poly glycol monomethyl ether acyl chlorides=1:1 ~ 10:1; Temperature of reaction is 10 DEG C ~ 80 DEG C; Reaction times is 0.5h ~ 10h;
Step 5, after reaction terminates, removing trichloromethane and unreacted triethylamine, add the hydrochloride that tetrahydrofuran (THF) is settled out triethylamine, centrifugation, and supernatant liquid removing tetrahydrofuran (THF) adds anhydrous diethyl ether again and is settled out reaction product.
3. Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 2, is characterized in that the powdered soybean phospholipid described in step 1 adopts extraction by propanone preparation; Poly glycol monomethyl ether carboxy derivatives described in step 2 adopts Jones reagent oxidation poly glycol monomethyl ether legal system standby, and wherein the molecular weight ranges of poly glycol monomethyl ether is 1200 ~ 5000.
4. Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 2, is characterized in that the poly glycol monomethyl ether acyl chlorides described in step 3 adopts thionyl chloride and the preparation of poly glycol monomethyl ether carboxy derivatives.
5. Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 2, is characterized in that in amount of substance ratio in step 4, poly glycol monomethyl ether acyl chlorides: triethylamine=1:10 ~ 1:40.
6. Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 2, it is characterized in that, the amount of substance of the poly glycol monomethyl ether acyl chlorides described in step 4 and the volume ratio=1:30 ~ 1:100mmol/ml of the tetrahydrofuran (THF) described in step 5, the amount of substance of poly glycol monomethyl ether acyl chlorides and the volume ratio=1:30 ~ 1:100mmol/ml of anhydrous diethyl ether.
7. a preparation for Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative, is characterized in that concrete steps are as follows:
Step 1, prepare powdered soybean phospholipid with phospholipid of natural soybean;
Step 2, prepare poly glycol monomethyl ether carboxy derivatives with poly glycol monomethyl ether;
Step 3, prepare poly glycol monomethyl ether acyl chlorides with poly glycol monomethyl ether carboxy derivatives;
Step 4, with powdered soybean phospholipid and poly glycol monomethyl ether acyl chlorides for raw material, take trichloromethane as solvent, take triethylamine as catalyzer, preparation Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative, wherein by quality ratio, powdered soybean phospholipid: poly glycol monomethyl ether acyl chlorides=1:1 ~ 10:1; Temperature of reaction is 10 DEG C ~ 80 DEG C; Reaction times is 0.5h ~ 10h;
After step 5, reaction terminate, removing trichloromethane and unreacted triethylamine, add the hydrochloride that tetrahydrofuran (THF) is settled out triethylamine, centrifugation, and supernatant liquid removing tetrahydrofuran (THF) adds anhydrous diethyl ether again and is settled out reaction product.
8. the preparation of Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 7, is characterized in that the powdered soybean phospholipid described in step 1 adopts extraction by propanone preparation; Poly glycol monomethyl ether carboxy derivatives described in step 2 adopts Jones reagent oxidation poly glycol monomethyl ether legal system standby, and wherein the molecular weight ranges of poly glycol monomethyl ether is 1200 ~ 5000; Poly glycol monomethyl ether acyl chlorides described in step 3 adopts thionyl chloride and the preparation of poly glycol monomethyl ether carboxy derivatives.
9. the preparation of Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 7, is characterized in that in amount of substance ratio in step 4, poly glycol monomethyl ether acyl chlorides: triethylamine=1:10 ~ 1:40.
10. the preparation of Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative according to claim 7, it is characterized in that, the amount of substance of the poly glycol monomethyl ether acyl chlorides described in step 4 and the volume ratio=1:30 ~ 1:100mmol/ml of the tetrahydrofuran (THF) described in step 5, the amount of substance of poly glycol monomethyl ether acyl chlorides and the volume ratio=1:30 ~ 1:100mmol/ml of anhydrous diethyl ether.
CN201310541744.XA 2013-11-05 2013-11-05 Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof Expired - Fee Related CN103626993B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310541744.XA CN103626993B (en) 2013-11-05 2013-11-05 Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310541744.XA CN103626993B (en) 2013-11-05 2013-11-05 Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof

Publications (2)

Publication Number Publication Date
CN103626993A CN103626993A (en) 2014-03-12
CN103626993B true CN103626993B (en) 2016-01-20

Family

ID=50208461

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310541744.XA Expired - Fee Related CN103626993B (en) 2013-11-05 2013-11-05 Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof

Country Status (1)

Country Link
CN (1) CN103626993B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3886579T3 (en) * 2018-11-30 2023-08-28 Icoat Medical Ab EX VIVO ORGAN TREATMENT USING PEG-PHOSPHOLIPIDE MOLECULES
CN112390942A (en) * 2019-08-17 2021-02-23 南京理工大学 Hydroxylated soybean phosphatidylethanolamine-methoxypolyethylene glycol, preparation method and application thereof
CN114796055B (en) * 2022-05-19 2023-08-15 广东艾粒生物科技有限责任公司 Whitening dressing rich in liposome nanoparticles and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100486646C (en) * 2007-01-17 2009-05-13 东南大学 Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy
CN102649841A (en) * 2012-04-06 2012-08-29 东南大学 Polyethylene glycol-modified phospholipid derivative taking anilino-quinazoline as targeting ligand and preparation method thereof
CN103263674A (en) * 2013-05-08 2013-08-28 上海纳米技术及应用国家工程研究中心有限公司 Tumor targeting material with tumor penetrating property, preparation method and applications thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100486646C (en) * 2007-01-17 2009-05-13 东南大学 Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy
CN102649841A (en) * 2012-04-06 2012-08-29 东南大学 Polyethylene glycol-modified phospholipid derivative taking anilino-quinazoline as targeting ligand and preparation method thereof
CN103263674A (en) * 2013-05-08 2013-08-28 上海纳米技术及应用国家工程研究中心有限公司 Tumor targeting material with tumor penetrating property, preparation method and applications thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
聚乙二醇单甲醚羧基衍生物的制备;陈龙等;《精细化工》;20131031;第30卷(第10期);第1177-1180、1197页 *

Also Published As

Publication number Publication date
CN103626993A (en) 2014-03-12

Similar Documents

Publication Publication Date Title
Yang et al. Drug delivery using nanoparticle-stabilized nanocapsules
Lesoin et al. Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method
CN105056213B (en) A kind of supermolecule nano ball of glucose responding and its preparation method and application
CN103626993B (en) Polyethylene glycol monomethyl ether soybean phosphatidyl ethanolamine derivative and preparation thereof
Qindeel et al. New, environment friendly approach for synthesis of amphiphilic PCL–PEG–PCL triblock copolymer: an efficient carrier for fabrication of nanomicelles
Liu et al. Preparation and characterization of paclitaxel/chitosan nanosuspensions for drug delivery system and cytotoxicity evaluation in vitro
CN103284950B (en) Sebum liposome and preparation method for same
Kashyap et al. Thermo-responsive and shape transformable amphiphilic scaffolds for loading and delivering anticancer drugs
Arshad et al. Synthesis of lipid-based amphiphilic block copolymer and its evaluation as nano drug carrier
CN102391498A (en) Polyethylene glycol di-fatty acid glyceride derivatives and application thereof to medicine delivery
CN101343540A (en) Method for preparing quantum dots using hyperbranched polymer supramolecular nanoreactor
CN105326792B (en) Target liposomes wrap up the preparation method of aqueous phase nano-Au composite
JP2019518096A (en) Amphiphilic polymer
Demirdogen et al. Preparation of novel CaMoO4: Eu3+-MCM-41 nanocomposites and their applications and monitoring as drug release systems
Wang et al. Micellization and single-particle encapsulation with dimethylammoniopropyl sulfobetaines
CN106083993B (en) Amphiphilic polypeptide dendrimers and preparation methods thereof
Guo et al. Well-defined podophyllotoxin polyprodrug brushes: preparation via RAFT polymerization and evaluation as drug carriers
Wu et al. Synthesis and micellization of a new amphiphilic star-shaped poly (D, L-lactide)/polyphosphoester block copolymer
Wu et al. Synthesis and micellization of amphiphilic biodegradable methoxypolyethylene glycol/poly (d, l-lactide)/polyphosphate block copolymer
CN104689321B (en) Curcumin long-circulating nanoliposome carrier of enoxolone mediation and preparation method thereof
Li et al. Self-assembly of nanoparticles from cyclotriphosphazenes grafted with hexa-[p-(carbonyl tryptophan ethyl ester) phenoxy)] group
CN107412181B (en) Preparation method for controlling release of lipid nanoparticles by using amphiphilic bletilla striata gum skeleton
Guo et al. A codendrimer of PAMAM decorated with oligoethylene glycol dendrons: synthesis, self-assembly, and application as a drug carrier
CN109172524A (en) A kind of Puerarin micella and preparation method thereof, puerarin preparation
CN108186573A (en) It is a kind of using lipid encapsulation mesoporous silicon oxide as hydroxycamptothecin Liver targeting preparation of carrier and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160120

Termination date: 20211105